摘要
To evaluate the effectiveness and feasibility of managing cancer and living meaningfully (CALM), an inter-vention used to reduce the fear of cancer recurrence (FCR) in breast cancer survivors and improve their quality of life (QoL). A total of 103 breast cancer survivors were enrolled. Participants were randomly assigned to the CALM group or the care as usual (CAU) group. The participants completed a survey at baseline (T0) and after two (T1), four (T2), and six (T3) intervention sessions. The patients were assessed using the Cancer Worry Scale (CWS), Psycho-logical Distress Thermometer (DT), Functional Assessment of Cancer Therapy-Breast (FACT-B) and Hospital Anxiety and Depression Scale (HADS). After the intervention, the CALM group showed a significant decrease in levels of FCR, distress, anxiety, and depression (?2=154.353, ?2=130.292, ?2=148.879, and ?2=78.681; P<0.001, 0.001, 0.001, and 0.001, respectively) and an increased QoL (?2=122.822, P<0.001). Compared with the CAU group, the CALM group showed significant differences in FCR, distress, QoL, anxiety and depression (F=292.431, F=344.156, F=11.115, F=45.124, and F=16.155; P<0.001, P<0.001, P=0.01, P<0.001, and P<0.001, respectively). Negative correlations were found between CWS and FACT-B scores in the CALM group (T0: r=-0.6345, P<0.001; T1: r=-0.4127, P=0.0017; T2: r=-0.2919, P=0.0306; and T3: r=-0.3188, P=0.0177) and in the CAU group (T0: r=-0.7714, P<0.0001; T1: r=-0.6549, P<0.0001; T2: r=-0.5060, P=0.0002; and T3: r=-0.3151, P=0.0291). Thus, the CALM intervention reduced FCR, distress, anxiety and depression in breast cancer survivors and improved QoL.
学科与关键词
- Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancerZhao, Jie; Wang, Menglian; Huang, Runze; Xu, Jian; Gan, Chen; Yu, Sheng; Tang, Lingxue; Yao, Senbang; Li, Wen; Cheng, Huaidong*Supportive Care in Cancer, 2023, 31(7): 447.
- Effects of the CALM intervention on resilience in Chinese patients with early breast cancer: a randomized trialLiu, Shaochun; Huang, Runze; Li, Anlong; Yu, Sheng; Yao, Senbang; Xu, Jian; Tang, Lingxue; Li, Wen; Gan, Chen; Cheng, Huaidong*Journal of Cancer Research and Clinical Oncology, 2023, 149(20): 18005-18021.
- Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemicPang, Lulian; Yao, Senbang; Li, Wen; Jing, Yanyan; Yin, Xiangxiang; Cheng, Huaidong*Supportive Care in Cancer, 2023, 31(2): 121.被引 1
